Wolfgang Miesbach: Can We ‘Pre‑Tame’ the Immune System to Unlock Better AAV8 FVIII Expression?
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn:
“The story of haemophilia gene therapy continues – in China.
Can we ‘pre‑tame’ the immune system to unlock better AAV8 FVIII expression?
A new phase 1 pilot study from Liu et al. (GS001, AAV8‑BDDFVIII) in Signal Transduction and Targeted Therapy tests exactly that: single‑dose, liver‑directed hemophilia A gene therapy plus prophylactic prednisone with or without tacrolimus in 12 adults with severe HA:
Rapid FVIII rise, with expression peaking at 5–7 weeks post‑infusion in both 2×10¹² and 4×10¹² vg/kg cohorts.
In the high‑dose group, median FVIII nearly 60 IU/dL at week 52 and nearly 43 IU/dL at week 104; all six patients stayed at least 29 IU/dL (non‑hemophilia / high mild range).
Annualized bleeding rate and FVIII consumption dropped sharply; in the high‑dose cohort, no bleeds requiring FVIII after gene therapy.
ALT/AST elevations were mostly grade 1–2, and single‑cell RNA‑seq plus in vitro assays suggest prednisone and tacrolimus specifically dampens CD8 T‑cell activation without major CD4 suppression.
Conceptually, this study pushes the idea that pre‑emptive, targeted immunosuppression can help secure higher, more durable FVIII levels at relatively modest AAV8 doses – highly relevant for countries with constrained resources and large haemophilia A populations.”

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 17, 2026, 05:47Multidisciplinary Teams Kick Off SAHF MASAC ES 2026 with Pre-Symposium Workshops – South African Haemophilia Foundation
-
Nov 17, 2026, 05:41Boitumelo Malatji: South African Delegation Advances Advocacy Strategies at NNHF Southern Africa Workshop
-
Nov 17, 2026, 05:36Joining the PACTA Uganda Mental Health and Addiction Community Camp 2026 – Tackle Sickle Cell Africa
-
Nov 17, 2026, 05:30Nathan Connell: Women’s Hematology Summit 2027 to Address Hematologic Health Across the Lifespan
-
Nov 17, 2026, 05:25Mane Kurghinyan: Representing Armenia and HemAI Dynamics at the Falling Walls Lab Global Finale 2026
-
Nov 17, 2026, 01:27X. Long Zheng: Optimizing Treatment in Immune TTP
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH